EDP-305 1 mg
EDP 305-201
Phase 2 small_molecule completed
Quick answer
EDP-305 1 mg for Primary Biliary Cholangitis is a Phase 2 program (small_molecule) at ENANTA PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ENANTA PHARMACEUTICALS INC
- Indication
- Primary Biliary Cholangitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed